¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ´ç´¢º´ÇÐȸ (¿Â¶óÀÎ) 2020 International Congress of Diabetes and Metabolism : 2020-09-18

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ´ç´¢º´ÇÐȸ (¿Â¶óÀÎ) 2020 International Congress of Diabetes and Metabolism : 2020-09-18
±³À°ÀÏÀÚ : 2020-09-18
±³À°Àå¼Ò : ¿Â¶óÀÎ ¿¬¼ö±³À°  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2020 International Congress of Diabetes and Metabolism      
ÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ
´ã´çÀÚ : ÀÌ¿¬ÁÖ
¿¬¶ôó : 02-714-9071  
À̸ÞÀÏ : diabetes@kams.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 1500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 150,000¿ø      
ºñ°í ºñ¸â¹ö ÀÇ»ç 15¸¸¿ø ¸â¹ö ÀÇ»ç 10¸¸¿ø ºñ¸â¹ö ºñÀÇ»ç 10¸¸¿ø ¸â¹ö ºñÀÇ»ç 5¸¸¿ø      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ09:10~09:40 SGLT2 inhibition and kidney protection in people without diabetes  David Z. Cherney(TRGRI Canada) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ09:40~10:10 Anti-diabetes drugs and proteinuria  Soon Hyo Kwon(Soonchunghyang University Korea) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ10:10~10:40 Anti-diabetes drugs and GFR  Sang Soo Kim(Pusan National University Korea) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ10:40~11:10 Multiomics approach in DKD research  Nan Hee Kim(Korea University Korea) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ11:30~12:00 Diabetes care: post COVID-19 new normal  Kun-Ho Yoon(The Catholic University of Korea Korea) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ12:00~12:30 Digital transformation of future medicine accelerated by COVID-19  Sungroh Yoon(Seoul National University Korea) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ12:50~13:10 Empagliflozin? potential role in T2D & complications  David Z. Cherney(TRGRI Canada) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ14:00~14:30 Lack of a legacy effect in patients with diabetes and cardiovascular disease  Neda Laiteerapong(The University of Chicago USA) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ14:30~15:00 Early intensive combination therapy in T2DM: pros and cons  Chang Hee Jung(University of Ulsan Korea) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ15:00~15:30 Strategy to achieve remission of diabetes: life style and metabolic surgery (direct trial (low calorie diet)  Hyuk Sang Kwon(The Catholic University of Korea Korea) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ15:30~16:00 Do we need to use SGLT2i/GLP-1RA in well-controlled diabetes with increased CV risk?  Roopa Mehta(INCMNSZ Mexico) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ16:20~16:50 Blood glucose, antidiabetic drugs, and stroke risk  Meng Lee(Chang Gung University Taiwan) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ16:50~17:20 Hypoglycemia and brain  Ji-Young Kim(Inje University Korea) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ17:20~17:50 Screening and diagnosis of diabetic peripheral arterial disease  Pil Hyung Lee(University of Ulsan Korea) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ17:50~18:20 Update of current treatment of diabetic peripheral arterial disease  Su Hong Kim(Busan Veterans Hospital Korea) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ´ç´¢º´ÇÐȸ (¿Â¶óÀÎ) 2020 International Congress of Diabetes and Metabolism : 2020-09-18""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ Á¦ 19 ȸ ºÎ»ê°æ³²Áßµ¶¿¬±¸È¸(ASBK) ¼¼¹Ì³ª & Çѱ¹Áßµ¶Á¤½ÅÀÇÇÐȸ ½ÉÆ÷Áö¾ö : 2020-09-18
´ÙÀ½±Û (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) Á¦76Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ Çмú´ëȸ(KCR 2020) 2ÀÏÂ÷ : 2020-09-18
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20908 ¼­¿ï Á¦19Â÷ ´ëÇѸðÀ¯¼öÀ¯ÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-07-07 0 18 2024-05-28
20907 °æ±â Á¦2Â÷ ´ëÇѽŰæ¹æ»ç¼±¼ö¼úÇÐȸ Á¤±âÇмú´ëȸ : 2024-07-06 0 17 2024-05-28
20906 °æ±â Á¦ 5ȸ ¿À»ê½ÃÀÇ»çȸ Çмú´ëȸ : 2024-07-06 0 18 2024-05-28
20905 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦3ȸ ¾Æ»êµÎ°æºÎ Æ÷·³ : 2024-07-06 0 21 2024-05-28
20904 ¼­¿ï 2024³â Á¦2ȸ °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø ¼øȯ±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-06 0 26 2024-05-28
20903 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day3) : 2024-07-06 0 20 2024-05-28
20902 ¼­¿ï ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ 2024³â ÇÏ°è NeurocrItical Care Essence (NICE) ¾ÆÄ«µ¥¹Ì : 2024-07-06 0 13 2024-05-28
20901 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦10ȸ ºÎ½Å¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-06 0 16 2024-05-28
20900 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day2) : 2024-07-05 0 7 2024-05-28
20899 ¼­¿ï ÀÓ»ó¼ú±â±³À°¿¬±¸È¸ Á¦16ȸ ÀÓ»ó¼ú±â ¿¬¼ö°­Á : 2024-07-04 0 18 2024-05-28
20898 °æ±â ¿ëÀμ¼ºê¶õ½ºº´¿ø µðÁöÅÐÀÇ·á½ÉÆ÷Áö¾ö -¹Ì·¡ ÀǷḦ À§ÇÑ ±³·ù¿Í Çù·Â : 2024-07-04 0 15 2024-05-28
20897 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day1) : 2024-07-04 0 10 2024-05-28
20896 ¼­¿ï ´ëÇÑ»êºÎÀΰúÇÐȸ ¼­ºÎÁöȸ Á¤±â Áý´ãȸ(Àڱ󻸷Áõ½ÄÁõ) : 2024-07-02 0 14 2024-05-28
20895 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 12 2024-05-28
20894 ´ëÀü Ãæ³²´ëÇб³º´¿ø 2024³â °³¿øÀÇ¿Í ÇÔ²²ÇÏ´Â ³»°ú ¿¬¼ö°­Á : 2024-06-30 0 32 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷